Detalles de la búsqueda
1.
Cardiovascular Safety of Testosterone-Replacement Therapy.
N Engl J Med
; 389(2): 107-117, 2023 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37326322
2.
Chronic opioid use and complication risks in women with endometriosis: A cohort study in US administrative claims.
Pharmacoepidemiol Drug Saf
; 30(6): 787-796, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33611812
3.
Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients.
BMC Womens Health
; 21(1): 246, 2021 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34134684
4.
Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease.
Am Heart J
; 224: 65-76, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32335402
5.
Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: analysis of 2 phase III clinical trials.
Am J Obstet Gynecol
; 222(6): 592.e1-592.e10, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31759891
6.
Clinically Meaningful Reduction in Dyspareunia Is Associated With Significant Improvements in Health-Related Quality of Life Among Women With Moderate to Severe Pain Associated With Endometriosis: A Pooled Analysis of Two Phase III Trials of Elagolix.
J Sex Med
; 17(12): 2427-2433, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32928659
7.
Patient-completed or symptom-based screening tools for endometriosis: a scoping review.
Arch Gynecol Obstet
; 296(2): 153-165, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28547097
8.
Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial.
JAMA Intern Med
; 184(4): 353-362, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38315466
9.
Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome.
F S Rep
; 4(2): 206-212, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37398623
10.
Low-Dose Elagolix for the Treatment of Heavy Menstrual Bleeding in Patients With Uterine Leiomyomas: A Randomized Controlled Trial.
Obstet Gynecol
; 142(5): 1068-1076, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37769311
11.
Development and Validation of ICD-10-CM-based Algorithms for Date of Last Menstrual Period, Pregnancy Outcomes, and Infant Outcomes.
Drug Saf
; 46(2): 209-222, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36656445
12.
Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial.
JAMA Netw Open
; 6(12): e2348692, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38150256
13.
A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder.
Am Heart J
; 163(1): 27-32, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22172433
14.
Responsiveness and thresholds for clinically meaningful changes in worst pain numerical rating scale for dysmenorrhea and nonmenstrual pelvic pain in women with moderate to severe endometriosis.
Fertil Steril
; 115(2): 423-430, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33066973
15.
Psychometric assessment of the PROMIS Fatigue Short Form 6a in women with moderate-to-severe endometriosis-associated pain.
J Patient Rep Outcomes
; 4(1): 86, 2020 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33108543
16.
Psychometric assessment of the health-related productivity questionnaire (HRPQ) among women with endometriosis.
Expert Rev Pharmacoecon Outcomes Res
; 20(5): 531-539, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31530044
17.
Responsiveness Evaluation and Recommendation for Responder Thresholds for Endometriosis Health Profile-30: Analysis of Two Phase III Clinical Trials.
J Womens Health (Larchmt)
; 29(2): 253-261, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31855102
18.
Estimating the Effect of Elagolix Treatment for Endometriosis on Postmenopausal Bone Outcomes: A Model Bridging Phase III Trials to an Older Real-World Population.
JBMR Plus
; 4(12): e10401, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33354641
19.
Approved hormonal treatments for HSDD: an unmet medical need.
J Sex Med
; 6(7): 1846-9, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19453872
20.
Impact of elagolix treatment on fatigue experienced by women with moderate to severe pain associated with endometriosis.
Fertil Steril
; 112(2): 298-304.e3, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30992150